John Truesdell
Chief Business Officer
John Truesdell is the Chief Business Officer of Foresight Diagnostics. John has broad experience across healthcare sales, marketing, life-cycle management, and business development. Before joining Foresight, he was the Chief Business Officer of SeQure Dx, where he built the market for NGS-based preclinical and clinical assessment of gene editing therapy. John also served in various leadership roles at Foundation Medicine, where he drove the development and commercialization of pioneering NGS companion diagnostic platforms that supported dozens of groundbreaking oncology drug launches. In addition, he held diverse commercial roles at Boston Scientific and Semprus BioSciences, now part of Teleflex. John is a military veteran, having served for more than a decade worldwide as a US Navy SEAL. He received his MBA from MIT Sloan School of Management, MS from the Harvard-MIT Division of Health Sciences and Technology, and BA in biochemistry and molecular, cellular, and developmental biology from the University of Colorado Boulder.
